Ernexa Therapeutics (ERNA) EBT Margin (2010 - 2026)
Ernexa Therapeutics (ERNA) posted EBT Margin of -30252.63% for Q4 2024, down 17687.33 percentage points from -12565.31% a year earlier and down 24792.26 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) EBT Margin (2010 - 2026) Analysis & Trends
For FY2024, Ernexa Therapeutics' EBT Margin came in at -7418.17%, up 14252.83 percentage points from FY2023.
- Annual EBT Margin shows a five-year change of -7407.97 percentage points (FY2019 to FY2024).
- In prior years, Ernexa Therapeutics' EBT Margin was -21671.00% in FY2023 and -125.71% in FY2020 (-115.51 pp).
- The Q4 2024 figure stands as the lowest quarterly EBT Margin in data going back to Q2 2010.
- According to Business Quant data, EBT Margin for the three prior quarters was -5460.37% (Q3 2024), -11757.45% (Q2 2024) and -14134.04% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.71 Bn | 1,136.29 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 647.75 Bn | 567.61 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.60 Bn | 476.71 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 303.19 Bn | 267.18 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 268.04 Bn | 241.73 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 242.69 Bn | 198.09 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.89 Bn | 169.09 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 173.31 Bn | 119.95 Bn | 10.94 Bn | -4.34% |
| 10 | Ernexa Therapeutics | 2.45 Mn | -16.70 Mn | - | -7,289.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7,289.09% |
| Mar 31, 2026 | -12,604.55% |
| Sep 30, 2025 | -3,980.65% |
| Mar 31, 2025 | -163,880.00% |
| Dec 31, 2024 | -30,252.63% |
| Sep 30, 2024 | -5,460.37% |
| Jun 30, 2024 | -11,757.45% |
| Mar 31, 2024 | -14,134.04% |
| Dec 31, 2023 | -12,565.31% |
| Sep 30, 2023 | -10,978.43% |
| Jun 30, 2023 | -18,766.67% |
| Dec 31, 2020 | -216.68% |
| Sep 30, 2020 | -101.56% |
| Mar 31, 2020 | -51.67% |
| Dec 31, 2019 | -25.08% |
| Sep 30, 2019 | -7.25% |
| Jun 30, 2019 | -1.72% |
| Mar 31, 2019 | -6.25% |
| Dec 31, 2018 | -0.81% |
| Sep 30, 2018 | 3.86% |
API Access
Ernexa Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();